PKR modulates abnormal brain signaling in experimental obesity.
Metabolic disorders including obesity and type 2 diabetes are known to be associated with chronic inflammation and are obvious risk factors for Alzheimer's disease. Recent evidences concerning obesity and diabetes suggest that the metabolic inflammasome ("metaflammasome") mediates chr...
Main Authors: | Mariko Taga, François Mouton-Liger, Malha Sadoune, Sarah Gourmaud, Jenny Norman, Marion Tible, Sylvie Thomasseau, Claire Paquet, James A R Nicoll, Delphine Boche, Jacques Hugon |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2018-01-01
|
Series: | PLoS ONE |
Online Access: | http://europepmc.org/articles/PMC5968403?pdf=render |
Similar Items
-
PKR involvement in Alzheimer’s disease
by: Jacques Hugon, et al.
Published: (2017-10-01) -
Blood-Based Kinase Assessments in Alzheimer’s Disease
by: Jacques Hugon, et al.
Published: (2018-11-01) -
Are ketogenic diets promising for Alzheimer’s disease? A translational review
by: Matthieu Lilamand, et al.
Published: (2020-04-01) -
Efficacy and Safety of Ketone Supplementation or Ketogenic Diets for Alzheimer's Disease: A Mini Review
by: Matthieu Lilamand, et al.
Published: (2022-01-01) -
Inverse association between CSF Aβ 42 levels and years of education in mild form of Alzheimer's disease: The cognitive reserve theory
by: Julien Dumurgier, et al.
Published: (2010-11-01)